Published in Artif Organs on July 01, 1998
Influence of an acetate- and a lactate-based balanced infusion solution on acid base physiology and hemodynamics: an observational pilot study. Eur J Med Res (2012) 0.81
Plasma-Lyte 148: A clinical review. World J Crit Care Med (2016) 0.75
Bicarbonate Balance and Prescription in ESRD. J Am Soc Nephrol (2016) 0.75
Hypersensitivity reactions to acetate in the bicarbonate dialysate in a patient undergoing pre-dilution online hemodiafiltration. CEN Case Rep (2015) 0.75
Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science (1999) 5.98
A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. Nature (1987) 3.96
Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus. Mol Microbiol (2001) 3.39
Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem (1999) 2.05
Structure of sortase, the transpeptidase that anchors proteins to the cell wall of Staphylococcus aureus. Proc Natl Acad Sci U S A (2001) 2.03
Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant (1993) 1.85
Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant (2001) 1.69
Transactivation and growth suppression by the gut-enriched Krüppel-like factor (Krüppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res (2000) 1.59
Crystallographic analysis of oxygenated and deoxygenated states of arthropod hemocyanin shows unusual differences. Proteins (1994) 1.58
[Epidemiology of end-stage kidney failure in the Ile-de-France: a prospective cooperative study in 1998]. Nephrologie (2000) 1.37
Anchor structure of staphylococcal surface proteins. II. Cooh-terminal structure of muramidase and amidase-solubilized surface protein. J Biol Chem (1998) 1.32
Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant (1997) 1.29
Structural study of circulating thymic factor: a peptide isolated from pig serum. I. Isolation and purification. J Biol Chem (1977) 1.28
Genetic diversity within Pisum sativum using protein- and PCR-based markers. Theor Appl Genet (2004) 1.15
Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant (1996) 1.12
Detrimental effects of late referral in patients with chronic renal failure: a case-control study. Kidney Int Suppl (1993) 1.06
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications. J Am Soc Nephrol (1998) 1.04
Anemia and secondary hyperparathyroidism. Arch Intern Med (1978) 1.02
One year follow-up of short dialysis with a membrane highly permeable to middle molecules. Proc Eur Dial Transplant Assoc (1973) 1.00
Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency. Nephron (1994) 0.94
Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors. Nephrol Dial Transplant (1995) 0.92
Hemofiltration, an alternative method for treatment of end-stage renal failure. Adv Nephrol Necker Hosp (1977) 0.90
[Synchronous bilateral renal cell carcinoma. Renal transplantation after nephrectomy]. Presse Med (1997) 0.89
Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol (1985) 0.88
Genetic heterogeneity of familial hyperkalaemic hypertension. J Hypertens (2001) 0.88
Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant (1999) 0.88
Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998. Nephrol Dial Transplant (2000) 0.88
Structural differences between the Streptococcus agalactiae housekeeping and pilus-specific sortases: SrtA and SrtC1. PLoS One (2011) 0.87
Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 0.87
Bilateral fracture of the femoral neck complicating uremic bone disease prior to chronic hemodialysis. Clin Nephrol (1974) 0.86
Phosphate removal rate: a comparative study of five high-flux dialysers. Nephrol Dial Transplant (1991) 0.84
Lipid peroxidation abnormalities in hemodialyzed patients. Nephron (1993) 0.83
Semiautomated method for measurement of guanidinosuccinic acid in serum. Clin Chem (1972) 0.83
Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families. Adv Nephrol Necker Hosp (2001) 0.83
In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin. Contrib Nephrol (1989) 0.82
Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease. J Inherit Metab Dis (1997) 0.81
Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron (1991) 0.81
[Benefits of early nephrological management in chronic renal failure]. Presse Med (1997) 0.80
Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: a multicentric study in the Ile de France district. Nephrol Dial Transplant (1999) 0.80
Calciphylaxis in a chronic hemodialysis patient with protein S deficiency. Am J Nephrol (1995) 0.80
The rate of progression of renal failure in ADPKD. Contrib Nephrol (1995) 0.79
The role of sodium in the prevention of vascular instability during haemodialysis. Proc Eur Dial Transplant Assoc (1981) 0.79
Assignment of the 1H, 13C and 15N signals of Sortase. J Biomol NMR (2001) 0.79
[Benefits of early nephrological management of chronic renal failure]. Presse Med (1997) 0.79
Experimental chronic renal failure in the rat by electrocoagulation of the renal cortex. Kidney Int (1978) 0.78
Evaluation of plasma sodium concentration during hemodialysis by computerization of dialysate conductivity. ASAIO Trans (1991) 0.78
[Effect of keto analogs of essential amino acids on the progress of advanced chronic renal insufficiency: controlled prospective study]. Nephrologie (1986) 0.77
Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Intensive Care Med (2001) 0.77
Kinetics of HCV viremia in kidney transplant recipients during and after alpha-interferon therapy. Am J Nephrol (1997) 0.77
Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney Int Suppl (1987) 0.77
[Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis]. Nephrologie (1991) 0.76
Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy. Kidney Int (1977) 0.76
Clinical use of oxystarch. Kidney Int Suppl (1976) 0.76
[Lactate and uric acid retention following oral diuretic drug administration in man]. Klin Wochenschr (1967) 0.76
[Risk factors for acute hypersensitivity reactions in hemodialysis]. Nephrologie (1996) 0.76
Effectiveness of various chemical disinfectants versus cleaning combined with heat disinfection on Pseudomonas biofilm in hemodialysis machines. Blood Purif (2004) 0.75
Kinetics of cisplatin in an anuric patient undergoing hemofiltration dialysis. Cancer Treat Rep (1981) 0.75
Dialysis therapy. N Engl J Med (1998) 0.75
[Accidental lithium poisoning in a patient with chronic hemodialysis]. Nouv Presse Med (1975) 0.75
Leukopenia and complement activation induced by different dialysis membranes. Contrib Nephrol (1984) 0.75
Membrane transfer, membrane adsorption and possible membrane-induced generation of beta-2-microglobulin. Contrib Nephrol (1989) 0.75
[Self dialysis: a new method of treatment for end-stage renal disease]. Nephrologie (1984) 0.75
Clinical implementation of sodium modeling. A reappraisal. Contrib Nephrol (1989) 0.75
[The future of hemodialysis in the adult]. Bull Acad Natl Med (1991) 0.75
Influence of the surface area of different dialysis membranes on granulocyte adherence and superoxide generation. Artif Organs (1988) 0.75
Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant (1992) 0.75
Kinetics of technetium-labeled heparin in hemodialyzed patients. Kidney Int Suppl (1993) 0.75
Phosphate kinetics in acetate-free biofiltration. Nihon Jinzo Gakkai Shi (1991) 0.75
The estimation of whole blood viscosity by a porous bed method. Am J Clin Pathol (1991) 0.75
Accumulation of 5 alpha-reduced androgen glucosiduronates associated with impaired removal in young male hemodialysis patients. J Clin Endocrinol Metab (1995) 0.75
Semi-automated determination of the uremic toxin "b4-2". Clin Chem (1984) 0.75
Noninvasive and invasive blood flowmetry in hemodialyzed patients with high blood flow fistulas. Trans Am Soc Artif Intern Organs (1984) 0.75
Optimization of Na content of dialysis fluid. Nephron (1984) 0.75
The most suitable calculation of Kt/V-urea: Kt/V = ln(Ci/Cf). Nihon Jinzo Gakkai Shi (1993) 0.75
[Bicarbonate-containing dialysate: a critical study]. Nephrologie (1983) 0.75
Characterization and identification of substances isolated from dialyzer extracts. Artif Organs (1988) 0.75
In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production. Contrib Nephrol (1989) 0.75
[The Carboclip, a new, atraumatic vascular access for hemodialysis]. Nephrologie (1994) 0.75
[Role of halophilic and halotrophic bacteria in the chronic problems of long-term dialysis]. Bull Acad Natl Med (1987) 0.75
Drug interaction in middle molecule analysis, with special reference to acetylsalicylic acid. Artif Organs (1984) 0.75
[Functions and metabolism of polynuclear neutrophils in patients under chronic hemodialysis]. Nephrologie (1987) 0.75
[Modelling in hemodialysis. Why? How?]. Nephrologie (1985) 0.75
Evaluation of parameters for adequate dialysis therapy: (1). Monitoring of parameters by urea kinetic modeling. Nihon Jinzo Gakkai Shi (1991) 0.75
[On the question of an extrarenal cause for uric acid retention after furosemide]. Verh Dtsch Ges Inn Med (1967) 0.75
[The clinical value of correction of acidosis by acetate-free biofiltration in patients on regular dialysis treatment]. Nihon Jinzo Gakkai Shi (1990) 0.75
Continuous ambulatory EEG monitoring following desferrioxamine (DFO) i.v. infusion. Trans Am Soc Artif Intern Organs (1985) 0.75
Clinical validation of a predictive modeling equation for sodium. Artif Organs (1985) 0.75
[Demography and effects of chronic renal insufficiency in Ile-de-France]. Nephrologie (1996) 0.75
Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.75
Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine. Trans Am Soc Artif Intern Organs (1984) 0.75
Blood density monitoring during dialysis. Artif Organs (1996) 0.75
Initiation of dialysis: when? Nihon Jinzo Gakkai Shi (1992) 0.75
Urea rebound and residual renal function in the calculation of Kt/V and protein catabolic rate. Kidney Int Suppl (1993) 0.75
[Advantage of a high-sodium hemodialysis solution: theoretical bases]. Nephrologie (1983) 0.75
[Preserved saphenous grafts in hemodialysis. 20 years' experience]. Nephrologie (1994) 0.75
[Bicarbonate dialysis: comparative study of its long-term effects]. Nephrologie (1983) 0.75
Cardiovascular stability on hemodialysis. Adv Nephrol Necker Hosp (1987) 0.75
Plasma histamine levels and kinetics in chronic hemodialysis patients. ASAIO Trans (1990) 0.75
[Treatment of chronic kidney failure by the keto-analogs of essential amino acids: 4 years' experience]. Presse Med (1987) 0.75
Sodium modeling during hemodialysis: a new approach. Artif Organs (1984) 0.75